AI assistant
Sending…
IMMUNIC, INC. — Director's Dealing 2021
Aug 11, 2021
10196_dirs_2021-08-11_99b51272-9062-4053-87d5-52666c37c755.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2021-08-10
Reporting Person: Vitt Daniel (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-10 | Common Stock | P | 1000 | $9.60 | Acquired | 363877 | Indirect |
Footnotes
F1: 1,000 shares are owned directly by the Reporting Person and 362,877 shares are owned by Listrax UG (haftungsbeschrankt). The Reporting Person is Managing Director of Listrax UG and exercises voting and dispositive power over such shares.
More from IMMUNIC, INC.
Regulatory Filings
2026
May 28
Board/Management Information
2026
May 27
Board/Management Information
2026
May 19
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Earnings Release
2026
May 13
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 28
Board/Management Information
2026
Apr 28
Regulatory Filings
2026
Apr 23